What is the BCAL Diagnostics (ASX: BDX) share price?
The BDX share price is $0.077, down 7.23% for the day, based on the latest available ASX market data.
What is BCAL Diagnostics's market capitalisation?
BCAL Diagnostics has a market capitalisation of $28.4M, making it the 1178th-largest security listed on the ASX.
Does BCAL Diagnostics pay a dividend?
BDX does not currently have a dividend on record. Some companies, particularly those reinvesting in growth or not yet profitable, do not pay dividends.
Is BCAL Diagnostics profitable?
In its most recent reported period (ending 31 Dec 2025), BDX reported revenue of $42,618 and a net loss of $3.9M.
How many BDX shares are on issue?
BCAL Diagnostics has approximately 368,683,000 shares on issue, based on its market capitalisation of $28.4M and current share price.
What sector is BCAL Diagnostics in?
BCAL Diagnostics is classified in the Healthcare sector, within the Medical - Diagnostics & Research industry on the ASX.
When did BCAL Diagnostics list on the ASX?
BCAL Diagnostics listed on the Australian Securities Exchange on 21 July 2021.
